(4-(((2-amino-7-methyl-4-oxo-1,4-dihydropteridin-6-yl)methyl)amino)benzoyl)-L-glutamic acid

Catalog No. :
ACSAQL854
CAS No. :
6810-75-9
Molecular Formula :
C20H21N7O6
Molecular Weight :
455.43

IUPAC Name:(4-(((2-amino-7-methyl-4-oxo-1,4-dihydropteridin-6-yl)methyl)amino)benzoyl)-L-glutamic acid

(4-(((2-amino-7-methyl-4-oxo-1,4-dihydropteridin-6-yl)methyl)amino)benzoyl)-L-glutamic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
No pack options available.

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(4-(((2-amino-7-methyl-4-oxo-1,4-dihydropteridin-6-yl)methyl)amino)benzoyl)-L-glutamic acid
IUPAC Name(4-(((2-amino-7-methyl-4-oxo-1,4-dihydropteridin-6-yl)methyl)amino)benzoyl)-L-glutamic acid
Molecular FormulaC20H21N7O6
Molecular Weight455.43
SMILESCC1=C(CNC2=CC=C(C(=O)N[C@@H](CCC(=O)O)C(=O)O)C=C2)N=C2C(=O)N=C(N)NC2=N1
InChI KeyBZOCHAZPJDIZAC-LBPRGKRZSA-N
SynonymFolinic Acid IMpurity G;Folic Acid EP Impurity G;N-{4-[(2-amino-7-methyl-4-oxo-3,4-dihydro-pteridin-6-ylmethyl)-amino]-benzoyl}-glutamic acid;(4-((2-amino-7-methyl-4-oxo-1,4-dihydropteridin-6-yl)amino)benzoyl)-L-glutamic acid;L-Glutamic acid, N-[4-[[(2-amino-1,4-dihydro-7-methyl-4-oxo-6-pteridinyl)methyl]amino]benzoyl]- (9CI);N-[4-[[(2-Amino-1,4-dihydro-7-methyl-4-oxo-6-pteridinyl)methyl]amino]benzoyl]-L-Glutamic Acid;Folinic Acid Impurity 16;Folic Acid Impurity 83
CAS No.6810-75-9

Synthetic Route by SureRoute

1. ACSAQL854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSAQL854 route product structure diagram
    ACSAQL8546810-75-9
Inquiry

2. ACSAQL854 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACSAQL854 route product structure diagram
    ACSAQL8546810-75-9
Inquiry

Comments (0)